UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: DiklofenakOrifarm50Enterotablett-SE-PLC-RA

Generated Narrative: RegulatedAuthorization DiklofenakOrifarm50Enterotablett-SE-PLC-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/19695

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00019695,http://ema.europa.eu/fhir/eurdId#1048; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Gastro-resistant tablet; indication = Diklofenak Orifarm 50 mg enterotablett är indicerat för behandling av nedanstående och är avsedd för vuxna och barn som väger mer än 50 kg. Reumatoid artrit. Juvenil reumatoid artrit. Artros. Mb. Bechterew. Dysmenorré utan organisk orsak.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = diclofenac

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2005-05-27

holder: Organization Orifarm Generics A/S

Cases

-TypeDate[x]
*First Authorisation2005-05-27